Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
New York State Journal of Medicine
|
December 1, 1989
Lead poisoning during home renovation
J P Curran, J R Nunez
New York State Journal of Medicine
|
November 1, 1989
Primary meningococcal conjunctivitis
J P Curran, J R Nunez, E Visconti
The Journal of Pharmacology and Experimental Therapeutics
|
May 6, 2004
Regional hemodynamic effects of the N-(2-benzoylphenyl)-L-tyrosine peroxisome proliferator-activated receptor-gamma ligand, GI 262570 [(S)-2-(2-benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic acid], in conscious rats
Sheila M Gardiner, Derek J R Nunez, Philip G Baer, et al.
Journal of Obesity
|
September 18, 2010
Assessment of acute and chronic pharmacological effects on energy expenditure and macronutrient oxidation in humans: responses to ephedrine
Antonella Napolitano, Peter R Murgatroyd, Nick Finer, et al.
Journal of Clinical & Translational Endocrinology
|
December 14, 2017
Exploring glycosuria as a mechanism for weight and fat mass reduction. A pilot study with remogliflozin etabonate and sergliflozin etabonate in healthy obese subjects
Antonella Napolitano, Sam Miller, Peter R Murgatroyd, et al.
Annals of Transplantation
|
October 14, 2004
Non heart beating donors. Succesfully expanding the donor's pool
F del Río Gallegos, J R Nunez Pena, A Soria García, et al.
Obesity (Silver Spring, Md.)
|
August 22, 2009
Quantitative magnetic resonance (QMR) for longitudinal evaluation of body composition changes with two dietary regimens
Khin Swe Myint, Antonella Napolitano, Sam R Miller, et al.
Journal of Clinical Pharmacology
|
March 5, 2010
Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study
Elizabeth K Hussey, Robert L Dobbins, Randall R Stoltz, et al.
Clinical Pharmacology and Therapeutics
|
June 26, 2009
Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors
J A Wagner, E C Wright, M M Ennis, et al.
Clinical Pharmacology and Therapeutics
|
April 22, 2010
The Biomarkers Consortium: practice and pitfalls of open-source precompetitive collaboration
J A Wagner, M Prince, E C Wright, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
New York State Journal of Medicine
|
December 1, 1989
Lead poisoning during home renovation
J P Curran, J R Nunez
New York State Journal of Medicine
|
November 1, 1989
Primary meningococcal conjunctivitis
J P Curran, J R Nunez, E Visconti
The Journal of Pharmacology and Experimental Therapeutics
|
May 6, 2004
Regional hemodynamic effects of the N-(2-benzoylphenyl)-L-tyrosine peroxisome proliferator-activated receptor-gamma ligand, GI 262570 [(S)-2-(2-benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic acid], in conscious rats
Sheila M Gardiner, Derek J R Nunez, Philip G Baer, et al.
Journal of Obesity
|
September 18, 2010
Assessment of acute and chronic pharmacological effects on energy expenditure and macronutrient oxidation in humans: responses to ephedrine
Antonella Napolitano, Peter R Murgatroyd, Nick Finer, et al.
Journal of Clinical & Translational Endocrinology
|
December 14, 2017
Exploring glycosuria as a mechanism for weight and fat mass reduction. A pilot study with remogliflozin etabonate and sergliflozin etabonate in healthy obese subjects
Antonella Napolitano, Sam Miller, Peter R Murgatroyd, et al.
Annals of Transplantation
|
October 14, 2004
Non heart beating donors. Succesfully expanding the donor's pool
F del Río Gallegos, J R Nunez Pena, A Soria García, et al.
Obesity (Silver Spring, Md.)
|
August 22, 2009
Quantitative magnetic resonance (QMR) for longitudinal evaluation of body composition changes with two dietary regimens
Khin Swe Myint, Antonella Napolitano, Sam R Miller, et al.
Journal of Clinical Pharmacology
|
March 5, 2010
Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study
Elizabeth K Hussey, Robert L Dobbins, Randall R Stoltz, et al.
Clinical Pharmacology and Therapeutics
|
June 26, 2009
Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors
J A Wagner, E C Wright, M M Ennis, et al.
Clinical Pharmacology and Therapeutics
|
April 22, 2010
The Biomarkers Consortium: practice and pitfalls of open-source precompetitive collaboration
J A Wagner, M Prince, E C Wright, et al.
Page
of 2